Financial Performance & Growth - FY21 sales reached over $1.3 billion, with a 20.7% sales growth[14] - FY21 Adjusted EBITDA was $271 million, reflecting a 48.0% growth[14] - First half of Fiscal Year 2022 (1H22) sales were $413 million, a 22% increase[26] - 1H22 Adjusted EBITDA grew by 5.5% to $10 million, with an Adjusted EBITDA margin of 2.4%[26] - The company revised its Fiscal Year 2022 sales guidance to $1.575 billion - $1.610 billion, representing a 17%-20% growth[30] - Revised Fiscal Year 2022 Adjusted EBITDA guidance is $315 million - $330 million, a 16%-22% increase[30] Strategic Initiatives & Market Position - The U.S pool & spa aftermarket opportunity is estimated at $14 billion[21] - The company operates 970 locations across 39 states[23, 29] - Digital properties capture 60% of specialty direct-to-consumer pool traffic[23] - The PRO business grew by 27% in 1H22 and accounts for approximately 15% of Last Twelve Months (LTM) total sales[29]

Company Overview - Leslie's is the largest direct-to-consumer brand in the pool and spa care industry, with fiscal year 2021 sales exceeding $1.3 billion, representing a 20.7% sales growth[14] - The company's adjusted EBITDA for fiscal year 2021 was $271 million, a 48% increase[14] - Leslie's operates 970 locations across 39 states[24] Market Opportunity - The U S pool and spa aftermarket opportunity is estimated at $14 billion[22, 35] - The addressable market includes 8.7 million residential pools representing a $7.6 billion total addressable market (TAM)[31] - There are 5.5 million addressable spas representing a $2 billion TAM[33] - The professional pool market includes 250,000 commercial pools and 45,000 pool professionals, representing a $4.3 billion TAM[35] Growth & Financial Performance - First half of fiscal year 2022 sales reached $413 million, a 22% increase[82] - The company's first half of fiscal year 2022 adjusted EBITDA grew by 5.5% to $10 million[82] - The PRO business grew by 27% in the first half of fiscal year 2022 and represents approximately 15% of last twelve months (LTM) total sales[85] Fiscal Year 2022 Guidance - Revised fiscal year 2022 sales guidance is between $1.575 billion and $1.61 billion, representing a 17%-20% growth[89] - Revised fiscal year 2022 adjusted EBITDA is projected to be between $315 million and $330 million, a 16%-22% increase[89]

Financial Performance - Net sales decreased by 4.7% to $685.1 million compared to $718.6 million in Q1 2013 [12] - Reported EPS decreased by 14% to $0.69, primarily due to a Venezuela remeasurement loss [4] - Adjusted EPS decreased by 1% to $0.91 [4] - Reported operating income margin was 11.7%, down 60 basis points, while adjusted operating income margin was 14.3%, up 50 basis points [4] - The company returned $70 million in cash to shareholders through share repurchases and dividends [4] Sales Volume and Market Trends - Sales volume decreased by 5.0% [4] - Q1-2014 volume trends improved in March, but March and April volume run-rates remain below prior year levels [6] - Net Sales in North America decreased by 4.2% to $401.9 million [14] - Net Sales in Europe decreased by 4.6% to $105.4 million [16] - Net Sales in Asia Pacific decreased by 12.5% to $61.3 million [18] - Net Sales in Venezuela increased by 20.9% to $44.0 million [20] - Net Sales in The Harris Products Group decreased by 11.7% to $72.5 million [23] Capital Allocation - Dividends paid in Q1 2014 totaled $19 million, a 15% increase to $0.23 per common share [27] - Share repurchases in Q1 2014 increased by 299% to $51 million [28] - Capital expenditures in Q1 2014 decreased by 4% to $15 million [28]

Financial Performance - Q1 2013 - Net sales decreased by 1.2%, from $727.1 million in Q1 2012 to $718.6 million in Q1 2013[6] - Operating income decreased by 3.3%, from $91.7 million in Q1 2012 to $88.6 million in Q1 2013[6] - Adjusted operating income increased by 8.4%, from $91.7 million in Q1 2012 to $99.3 million in Q1 2013[6] - Net income increased by 4.0%, from $64.2 million in Q1 2012 to $66.8 million in Q1 2013[6] - Adjusted net income increased significantly by 20.1%, from $64.2 million in Q1 2012 to $77.1 million in Q1 2013[6] - Diluted EPS increased by 5.3%, from $0.76 in Q1 2012 to $0.80 in Q1 2013[6] - Adjusted diluted EPS increased by 21.1%, from $0.76 in Q1 2012 to $0.92 in Q1 2013[6] Segment Performance - North America welding segment net sales increased by 10.0%, from $381.3 million to $419.6 million, with an adjusted EBIT margin of 17.1%[16] - Europe welding segment net sales decreased by 12.2%, from $125.8 million to $110.5 million, with an adjusted EBIT margin of 9.3%[18] - Asia Pacific welding segment net sales decreased significantly by 24.3%, from $92.6 million to $70.0 million, but the adjusted EBIT margin increased to 3.1%[20] - The Harris Products Group net sales decreased by 6.3%, from $87.6 million to $82.1 million, but the adjusted EBIT margin improved to 8.5%[25] Capital Allocation - The company contributed $50 million to the U.S pension plan[29] - Share repurchases amounted to $12.8 million[30]

Financial Performance - Full Year 2013 - Record operating profit margin was reported at 14.3%, with an adjusted margin of 15.0%[4] - Record cash flow from operations reached $339 million[4] - Record EPS was reported at $3.54, with an adjusted EPS of $3.77[4] - The company achieved a solid ROIC of 18.9%[4] - A record $217 million was returned to shareholders through share repurchases and dividends[4] - Net sales remained relatively flat year-over-year at approximately $2.853 billion[5] Financial Performance - Q4 2013 - Net sales increased by 4.4% year-over-year to $714.8 million[11] - Operating income increased significantly by 38.7% year-over-year to $118.9 million[11] - Net income increased by 42.3% year-over-year to $88.3 million[11] - Diluted EPS increased by 44.6% year-over-year to $1.07[11] Capital Allocation - Dividends for FY2013 totaled $49 million, with a 15% increase announced for 2014[28, 30] - Share repurchases for FY2013 increased by 107% to $168 million[28, 30] - Capital expenditures for FY2013 increased by 43% to $76 million, driven by the Venezuela facility purchase[28, 30] Segment Performance - Q4 2013 - Americas net sales were $410 million, a 4.4% increase year-over-year, with an adjusted EBIT margin of 19.2%[13] - Europe, Middle East, and Africa net sales were $111.9 million, a 4.1% increase year-over-year, with an adjusted EBIT margin of 6.9%[15] - Asia Pacific net sales were $63.2 million, a 10.0% decrease year-over-year, with an adjusted EBIT margin of -0.2%[17] - South America net sales were $63.3 million, a substantial 58.5% increase year-over-year, with an adjusted EBIT margin of 39.8%[19] - The Other segment net sales were $66.4 million, a 10.3% decrease year-over-year, with an adjusted EBIT margin of 9.3%[20]

2020 Performance Highlights - Operating EPS reached $2.24, a 22% increase compared to 2019[11] - Operating Revenues totaled $7.31 billion, up 7% from 2019[11] - The combined ratio improved to 93.3, a 2-point improvement from 95.3 in 2019[11] - Book Value Per Share increased by 13% to $20.75, inclusive of dividends, from year-end 2019[11] - Shareholders' Equity rose to $6.19 billion, up from $6.00 billion at the end of 2019[11] 1st Quarter 2021 Highlights - Operating EPS increased by 47% to $0.69, from $0.47 in the first quarter of 2020, driven by underwriting strength in both General Insurance & Title[12] - Net Premiums & Fees Earned increased by 18% to $1.83 billion, driven by Title Insurance (up 40%) and General Insurance (up 1%)[12] - The combined ratio decreased by 4.2 points to 90.9, versus 95.1 last year[12] - Book Value Per Share was $21.59, up 5.1% from 4Q20, inclusive of dividends[12] Business Profile - General Insurance accounted for 53% and Title Insurance for 46% of the company's operating revenue in 2020[14] - The General Insurance segment had $3.8 billion in operating revenue with a steady 96 combined ratio over 15 years[14] - The Title Insurance segment had $3.3 billion in operating revenue with low 90's combined ratios[14] Dividend Record - The company has a shareholder-friendly dividend track record, paying dividends for 80 straight years and increasing the annual dividend for 40 straight years[33]

Regulatory and Legal Compliance Challenges - The introduction of a filing system for overseas listings in China starting in 2023 increases time costs and poses risks of failing to list if the filing is unsuccessful [2] - The SEC in the U.S. has strict disclosure requirements, particularly concerning audit working papers for Chinese companies, despite a cooperation agreement between China and the U.S. [2] - Domestic policies affecting industries like real estate and education may lead to scrutiny of business models [2] - Legal risks include the potential for delisting under the Foreign Company Accountability Act and compliance challenges with the FCPA [2] Strategies for Regulatory Compliance - Companies should plan early and understand U.S. regulatory requirements before preparing for listing [3] - Engaging a professional legal team familiar with both Chinese and U.S. securities laws is essential for compliance [3] - Establishing a robust internal control system is necessary to ensure the accuracy and transparency of financial reporting [3] Differences in Accounting Standards - Significant differences exist between Chinese Accounting Standards (CAS) and U.S. GAAP, affecting revenue recognition and asset impairment, which can impact company valuations [5] - Companies in sensitive industries must handle audit working papers carefully to balance compliance and disclosure [5] Strategies for Accounting Compliance - Companies should adjust financial statements according to GAAP before listing to meet U.S. regulatory requirements [6] - Hiring an auditing firm recognized by the PCAOB can enhance the credibility of financial reports [6] Investor Culture Differences - Information asymmetry may lead to U.S. investors undervaluing Chinese companies due to a lack of understanding of their business models [8] - U.S. investors prioritize long-term growth potential, innovation, and management execution, which may not be effectively communicated by traditional Chinese companies [8] - Short-selling firms may target Chinese stocks, necessitating enhanced financial transparency and crisis management capabilities [8] Strategies for Investor Engagement - Frequent roadshows can help companies understand U.S. investor culture and effectively communicate their core competencies and long-term plans [9] - Establishing a professional investor relations team and improving ESG reporting can enhance transparency and attract U.S. investors [10] Geopolitical Conflicts - Uncertainties in U.S.-China relations, including trade tensions and technology sanctions, can affect the listing process and stock prices [11] - Domestic policy tightening, such as data security reviews, requires timely assessments of listing feasibility [12] Strategies for Managing Geopolitical Risks - Companies should consider diversifying listing locations and financing channels to mitigate market volatility risks [13] - Strengthening communication with investors to convey stable operational information can enhance investor confidence [13] Information Security and Data Privacy - Strict compliance requirements under the Data Security Law and Personal Information Protection Law pose challenges for companies handling user data [15] - Conflicts between U.S. data disclosure requirements and Chinese regulations necessitate compliant data processing solutions [15] Strategies for Data Compliance - Companies should clearly outline data compliance measures in their prospectus and conduct data security assessments before data export [16] - Maintaining close communication with government departments can help secure policy support for cross-border data flow [16] High Listing Costs - The financial burden of listing in the U.S. includes underwriting, legal, accounting, and sponsorship fees, which can be significant for smaller companies [17] - Ongoing compliance costs post-listing, such as regular audit and disclosure expenses, can also be high [17] Strategies for Cost Management - Conducting thorough financial planning and cost-benefit analysis before deciding to list in the U.S. is crucial [18] - Introducing strategic investors prior to listing can alleviate financial pressure and ensure sufficient funding for the listing process and subsequent operations [18]

Company Overview - Ryan Specialty Group (RSG) is a rapidly growing provider of specialty products and solutions for insurance brokers, agents, and carriers[11] - RSG was founded in 2010[12] - As of September 30, 2021, RSG's LTM (Last Twelve Months) revenue was $1.4 billion[12] - RSG is the 2nd largest U S P&C wholesale broker[12] Financial Performance - RSG's organic revenue growth for the period ending September 30, 2021, YTD (Year-to-Date) was 25 6%[12] - RSG's LTM total revenue growth as of September 30, 2021, was 51 6%[12] - The Adjusted EBITDAC for LTM was $442 million[49] - The Adjusted EBITDAC Margin was 32 0%[49] Market Position and Growth Strategy - 71% of RSG's premiums are placed in the attractive E&S (Excess & Surplus) market[19] - The E&S market has experienced a CAGR (Compound Annual Growth Rate) of 6 4% compared to the admitted market's CAGR of 4 0% over the past decade[21] - RSG's revenue growth with the top 100 retail brokerage firms exceeded RSG's organic revenue growth of 20% in 2020[31] - RSG has completed over 40 acquisitions since its founding[31]

Company Overview - Ryan Specialty Group (RSG) was founded in 2010 and has grown to $1 billion in revenue by 2020[12] - RSG is the 2nd largest U S P&C wholesale broker and the largest U S P&C MGU[12] - The company experienced 20% organic revenue growth in 2020[12] - Total revenue growth in 2020 was 33%[12] Market Position and Strategy - 71% of RSG's premiums are placed in the E&S market[20] - The E&S market has a Compound Annual Growth Rate (CAGR) of 6 4% compared to the admitted market's 4 0% over the past decade[23] - RSG's revenue growth with the top 100 retail brokerage firms exceeded RSG's organic revenue growth of 20% in 2020[31] - Approximately $59 million of revenue was acquired in 2019, and $240 million in 2020 through strategic acquisitions[31] Financial Performance - Adjusted EBITDAC increased from $191 million in 2019 to $294 million in 2020[40] - The Adjusted EBITDAC Margin increased from 25% in 2019 to 29% in 2020[40] - The company's revenue increased from $765 million in 2019 to $1 018 billion in 2020[40]

Fred Lampropoulos will continue to serve as Chairman of Merit’s Board of Directors Merit announces preliminary unaudited revenue for the quarter ended June 30, 2025 SOUTH JORDAN, Utah, July 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today the appointment of Martha Aronson as Merit’s new President and Chief Executive Officer, effective October 3, 2025. Fred P. Lampropoulos will remain as Chairman of the Board, President and CEO ...